Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck

@article{Chikamatsu2007RelationshipsBR,
  title={Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck},
  author={K. Chikamatsu and K. Sakakura and T. Whiteside and N. Furuya},
  journal={Head \& Neck},
  year={2007},
  volume={29}
}
Homeostasis of circulating T cells is regulated in complex ways that have not yet been well defined. The balance between type 1 and type 2 T‐cell subsets in cancer patients is thought to modulate antitumor immunity. Meanwhile, CD4+CD25+ regulatory T cells (Treg), which are potent inhibitors of antitumor immune responses, also play an invaluable role in maintaining immune homeostasis. 
T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma
TLDR
This data indicates that T-helper and T-regulatory cells are particularly important in driving immune escape during HNSCC progression, and new insights into their mechanisms of action might support the development of effective and long-lasting immunotherapy. Expand
Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy
TLDR
The results suggested that, despite the immunosuppressive status in HNSCC patients, tumor‐specific immune responses mediated by CD8+ T cells might be induced and maintained. Expand
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
TLDR
A critical review of the understanding of the involvement of Regulatory T cells in controlling the T‐cell immune response in tumor occurrence and progression in HNSCC with an emphasis on current and future immunotherapeutic approaches involving regulatory T cells is presented. Expand
Increased frequency and suppressive activity of CD127low/− regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement
TLDR
Peripheral Treg cells, identified by the CD127low/− phenotype, have been shown to be influenced by a patient's tumour stage and/or nodal status in HNSCC; suggesting a role in tumour progression that could be manipulated by future immunotherapy. Expand
Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer
TLDR
Highly suppressive, cisplatin-resistant Treg increase in frequency and persist after CRT and could be responsible for suppression of antitumor immune responses and recurrence in HNSCC. Expand
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
TLDR
Examination of blood count and tumour markers used at time of diagnosis could be helpful for prognostication in HNSCC patients and aid improvement of treatment strategy. Expand
Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
TLDR
Several immune system abnormalities in LSCC patients are represented by expansion of functionally activated Tregs, both in the circulation and tumor microenvironment along with decreased frequencies of naïve T-cell populations and Th1- cell populations. Expand
T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness.
TLDR
An association of CD4 with poor prognosis, while CD25 expression is related with favorable prognosis is suggested from the heterogeneity of TIL subsets that display an antagonistic role in tumor immune cell response. Expand
Study of Immune Effector Cells in Leukoplakia and Oral Cancer
TLDR
Investigation of circulating Leukocyte and T cell subsets seems to be useful for predicting patient’s survival and to identify immunosuppressed patients who may be benefited with immunotherapy. Expand
Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma
TLDR
In dogs, Treg appears to suppress Type 1 immunity, which may be responsible for anti‐tumor responses, and the percentage of Treg increases with the tumor stage in the peripheral blood of dogs with oral malignant melanoma. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck
TLDR
The results suggest that the decreased proportion of circulating DCs and decreased HLA-DR expression in DCs may have a major impact on systemic immune responses in patients with SCCHN. Expand
T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis.
TLDR
The results indicate the dominance of T type 1 cells and T-cell-mediated immunity in B-CLL patients that is however shifted towards T type 2 during disease progression. Expand
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1
TLDR
It is concluded that the prevalence of Treg is increased in the peripheral blood as well as in the tumor microenvironment of patients with invasive breast or pancreas cancers, and may partly explain the poor immune response against tumor Ags. Expand
Control of immune homeostasis by naturally arising regulatory CD4+ T cells.
CD4(+)CD25(+) regulatory T (T(R)) cells are essential negative regulators of multiple immune functions. Their development and function are critically dependent on the forkhead transcription factorExpand
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy.
TLDR
Using multicolor flow cytometry and apoptosis assays, it is found that CD8+CD95+Annexin+ T cells are dying at a rate that is significantly higher in patients with cancer than in normal controls (NC). Expand
T lymphocyte differentiation in the periphery.
  • K. Murphy
  • Biology, Medicine
  • Current opinion in immunology
  • 1998
TLDR
Advances in Th1 development have included greater understanding of IL-12 receptors in Th2 development, data regarding IFN-gamma gene expression and clarification of the action of the new cytokine IL-18. Expand
Expression of Pro- and Antiapoptotic Proteins in Circulating CD8+ T Cells of Patients with Squamous Cell Carcinoma of the Head and Neck
TLDR
Apoptosis of circulating CD8+T cells is found in SCCHN patients with AD or NED, and up-regulated Bax and Bcl-XL expression, the elevated Bax/Bcl-2 ratio and its association with ANX binding implicate the mitochondrial pathway in death ofCD8+ T cells of patients with SCCHn. Expand
Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers.
TLDR
Th2-dominant status develops in cancer patients as well as healthy volunteers, and lymphocyte evaluations could find applications in diagnosis and therapeutic monitoring of cancer patients. Expand
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
TLDR
The data indicate that the Fas/FasL pathway is involved in spontaneous apoptosis of circulating Fas(+) T lymphocytes in cancer patients and might lead to excessive turnover of T cells in the circulation and, consequently, to reduced immune competence in patients with HNC. Expand
Disregulated Expression of the Th2 Cytokine Gene in Patients with Intraoral Squamous Cell Carcinoma
TLDR
It seems that the development of oral squamous cell carcinoma leads to polarization of cytokine gene expression that is skewed towards the Th1‐like response in the early stage, however, increasing tumour load and lymphnode invasion suppresses Th1 cytokine genes, thus skewing it toward a Th2‐like cytokine response. Expand
...
1
2
3
4
...